Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 905

1.

Protocol for a prospective, controlled, observational study to evaluate the influence of hypoxia on healthy volunteers and patients with inflammatory bowel disease: the Altitude IBD Study.

Vavricka S, Ruiz PA, Scharl S, Biedermann L, Scharl M, de Vallière C, Lundby C, Wenger RH, Held L, Merz TM, Gassmann M, Lutz T, Kunz A, Bron D, Fontana A, Strauss L, Weber A, Fried M, Rogler G, Zeitz J.

BMJ Open. 2017 Jan 5;7(1):e013477. doi: 10.1136/bmjopen-2016-013477.

2.

Stroke: Temporal Trends and Association with Atmospheric Variables and Air Pollutants in Northern Spain.

Santurtún A, Ruiz PB, López-Delgado L, Sanchez-Lorenzo A, Riancho J, Zarrabeitia MT.

Cardiovasc Toxicol. 2016 Dec 19. [Epub ahead of print]

PMID:
27990617
3.

Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection.

Perelló C, Carrión JA, Ruiz-Antorán B, Crespo J, Turnes J, Llaneras J, Lens S, Delgado M, García-Samaniego J, García-Paredes F, Fernández I, Morillas RM, Rincón D, Porres JC, Prieto M, Lázaro Ríos M, Fernández-Rodríguez C, Hermo JA, Rodríguez M, Herrero JI, Ruiz P, Fernández JR, Macías M, Pascasio JM, Moreno JM, Serra MÁ, Arenas J, Real Y, Jorquera F, Calleja JL; Spanish Collaborative Group for the Study of the Use of Hepatitis C Direct-Acting Drugs..

J Viral Hepat. 2016 Dec 15. doi: 10.1111/jvh.12637. [Epub ahead of print]

PMID:
27976491
4.

Physiologically based pharmacokinetic toolkit to evaluate environmental exposures: Applications of the dioxin model to study real life exposures.

Emond C, Ruiz P, Mumtaz M.

Toxicol Appl Pharmacol. 2017 Jan 15;315:70-79. doi: 10.1016/j.taap.2016.12.007.

PMID:
27956220
5.

De Novo Donor-Specific Anti-Human Leukocyte Antigen Antibody Detection in Long-Term Adult Liver Transplantation.

San Segundo D, Alonso C, Ruiz P, Roman I, Arias-Loste MT, Cuadrado A, Puente A, Casafont F, López-Hoyos M, Crespo J, Fábrega E.

Transplant Proc. 2016 Nov;48(9):2980-2982. doi: 10.1016/j.transproceed.2016.08.037.

PMID:
27932124
6.

Serum Levels of Interleukin-34 During Acute Rejection in Liver Transplantation.

San Segundo D, Ruiz P, Irure J, Arias-Loste MT, Cuadrado A, Puente A, Casafont F, López-Hoyos M, Crespo J, Fábrega E.

Transplant Proc. 2016 Nov;48(9):2977-2979. doi: 10.1016/j.transproceed.2016.08.038.

PMID:
27932123
7.

Octogenarian Donors in Liver Transplantation.

Gastaca M, Guerra M, Alvarez Martinez L, Ruiz P, Ventoso A, Palomares I, Prieto M, Matarranz A, Valdivieso A, Ortiz de Urbina J.

Transplant Proc. 2016 Nov;48(9):2856-2858. doi: 10.1016/j.transproceed.2016.06.063.

PMID:
27932091
8.

Randomized trial of rATg/Daclizumab vs. rATg/Alemtuzumab as dual induction therapy in renal transplantation: Results at 8years of follow-up.

Ciancio G, Gaynor JJ, Guerra G, Sageshima J, Roth D, Chen L, Kupin W, Mattiazzi A, Tueros L, Flores S, Hanson L, Ruiz P, Vianna R, Burke GW 3rd.

Transpl Immunol. 2016 Nov 22. pii: S0966-3274(16)30129-0. doi: 10.1016/j.trim.2016.11.004. [Epub ahead of print]

PMID:
27888093
9.

Hepatic gene transcription profiles in turbot (Scophthalmus maximus) experimentally exposed to heavy fuel oil nº 6 and to styrene.

Diaz de Cerio O, Bilbao E, Ruiz P, Pardo BG, Martínez P, Cajaraville MP, Cancio I.

Mar Environ Res. 2017 Feb;123:14-24. doi: 10.1016/j.marenvres.2016.11.005.

PMID:
27846414
10.

CathepsinKCre mediated deletion of βcatenin results in dramatic loss of bone mass by targeting both osteoclasts and osteoblastic cells.

Ruiz P, Martin-Millan M, Gonzalez-Martin MC, Almeida M, González-Macias J, Ros MA.

Sci Rep. 2016 Nov 2;6:36201. doi: 10.1038/srep36201.

11.

Is staphylococci population from milk of healthy goats safe?

Ruiz P, Barragán I, Seseña S, Palop ML.

Int J Food Microbiol. 2016 Dec 5;238:146-152. doi: 10.1016/j.ijfoodmicro.2016.08.033.

PMID:
27620826
12.

Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis.

Solà E, Kerbert AJ, Verspaget HW, Moreira R, Pose E, Ruiz P, Cela R, Morales-Ruiz M, López E, Graupera I, Solé C, Huelin P, Navarro AA, Ariza X, Jalan R, Fabrellas N, Benten D, de Prada G, Durand F, Jimenez W, van der Reijden JJ, Fernandez J, van Hoek B, Coenraad MJ, Ginès P.

J Hepatol. 2016 Nov;65(5):914-920. doi: 10.1016/j.jhep.2016.07.003.

PMID:
27422752
13.

Intraoperative Portal Flow of Less Than 1 Liter per Minute After Orthotopic Liver Transplantation Is Not Associated Per Se With an Increased Rate of Early Graft Dysfunction.

Gastaca M, Prieto M, Valdivieso A, Ruiz P, Ventoso A, Palomares I, Matarranz A, Martinez-Indart L, Ortiz de Urbina J.

Transplant Proc. 2016 Sep;48(7):2495-2498. doi: 10.1016/j.transproceed.2016.08.028.

PMID:
27742333
14.

Pilot Randomized Trial of Tacrolimus/Everolimus vs Tacrolimus/Enteric-Coated Mycophenolate Sodium in Adult, Primary Kidney Transplant Recipients at a Single Center.

Ciancio G, Tryphonopoulos P, Gaynor JJ, Guerra G, Sageshima J, Roth D, Chen L, Kupin W, Mattiazzi A, Tueros L, Flores S, Hanson L, Powell RH, Ruiz P, Vianna R, Burke GW 3rd.

Transplant Proc. 2016 Jul-Aug;48(6):2006-10. doi: 10.1016/j.transproceed.2016.03.048.

PMID:
27569936
15.

CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment.

Hotta R, Ohira M, Matsuura T, Muraoka I, Tryphonopoulos P, Fan J, Tekin A, Selvaggi G, Levi D, Ruiz P, Ricordi C, Vianna R, Ohdan H, Waldmann H, Tzakis AG, Nishida S.

PLoS One. 2016 Aug 25;11(8):e0161618. doi: 10.1371/journal.pone.0161618.

16.

Favorable longterm outcomes of liver transplant recipients treated de novo with once-daily tacrolimus: Results of a single-center cohort.

Gastaca M, Valdivieso A, Bustamante J, Fernández JR, Ruiz P, Ventoso A, Testillano M, Palomares I, Salvador P, Prieto M, Montejo M, Suárez MJ, de Urbina JO.

Liver Transpl. 2016 Oct;22(10):1391-400. doi: 10.1002/lt.24514.

PMID:
27434676
17.

IFN-free therapy for HIV/HCV-coinfected patients within the liver transplant setting.

Londoño MC, Manzardo C, Rimola A, Ruiz P, Costa J, Forner A, Ambrosioni J, Agüero F, Laguno M, Lligoña A, Moreno A, Miró JM.

J Antimicrob Chemother. 2016 Nov;71(11):3195-3201.

PMID:
27402009
18.

Risk analysis of ischemic-type biliary lesions after liver transplant using octogenarian donors.

Gastaca M, Guerra M, Ruiz P, Ventoso A, Valdivieso A, Ortiz de Urbina J.

Liver Transpl. 2016 Oct;22(10):1443-4. doi: 10.1002/lt.24497. No abstract available.

PMID:
27339409
19.

Survival behaviour and virulence of the fish pathogen Vibrio ordalii in seawater microcosms.

Ruiz P, Poblete-Morales M, Irgang R, Toranzo AE, Avendaño-Herrera R.

Dis Aquat Organ. 2016 Jun 15;120(1):27-38. doi: 10.3354/dao03005.

PMID:
27304868
20.

Influence of immune activation on the risk of allograft rejection in human immunodeficiency virus-infected kidney transplant recipients.

Lorio MA, Rosa R, Suarez JF, Ruiz P, Ciancio G, Burke GW, Camargo JF.

Transpl Immunol. 2016 Sep;38:40-3. doi: 10.1016/j.trim.2016.06.001.

PMID:
27297667
Items per page

Supplemental Content

Support Center